Correction: Investigation of metformin analogues in targeting signaling molecules of head and neck cancer pathways by computational approaches

Key Points

• This research aims to evaluate how metformin analogues can inhibit specific biological molecules involved in head and neck cancer pathways.
• Employs in-silico approaches, including molecular docking and MD simulations
• Utilizes MM/PBSA free energy calculations to assess inhibition effects
• Identified key interactions between metformin analogs and cancer-related signaling molecules
• Demonstrated potential therapeutic benefits of metformin analogs for head and neck cancer